Download PDF
CC BY-NC-ND 4.0 · Exp Clin Endocrinol Diabetes 2022; 130(12): 821-827
DOI: 10.1055/a-1869-4159
Article

Screening for Gestational Diabetes Mellitus and Pregnancy Outcomes: Results from a Multicentric Study in Tajikistan

Dilnoza Pirmatova
1   Department of Obstetrics and Gynecology No 1, Avicenna Tajik State Medical University (ATSMU), Rudaki av., Dushanbe, Tajikistan
9   Center for International Health (CIH), LMU, Munich, Germany
,
Munavvara Dodkhoeva
1   Department of Obstetrics and Gynecology No 1, Avicenna Tajik State Medical University (ATSMU), Rudaki av., Dushanbe, Tajikistan
,
Uwe Hasbargen
2   Department of Obstetrics and Gynecology LMU Medical Center, Munich, Germany
,
Andreas W. Flemmer
3   Div. Neonatology, University Children’s Hospital and Perinatal Center, LMU Medical Center, Munich, Germany
,
Zulfiya Abdusamatzoda
4   Ministry of Health and Social Protection of the Population of the Republic of Tajikistan, Shevchenko, Dushanbe, Tajikistan
,
Khursheda Saburova
5   Department of Delivery, Khatlon Regional Clinical Hospital named after Buri Vokhidov, Bokhtar, Tajikistan
,
Nasiba Salieva
6   Department of Neonatology, State Institution Health Complex «Istiklol», N. Karaboev av. Dushanbe, Tajikistan
,
Surayyo Radzhabova
7   Department of Reproductive Health, City Health Center, Dushanbe, Tajikistan
,
Klaus G. Parhofer
8   Medical Department IV, LMU Medical Center, Munich, Germany
9   Center for International Health (CIH), LMU, Munich, Germany
› Author Affiliations Funding This study was supported by a grant from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung) to Klaus G. Parhofer (Förderkennzeichen 01DK14022).
› Further Information
Also available at
   Permissions and Reprints

Abstract

The prevalence of gestational diabetes parallels the prevalence of type 2 diabetes mellitus and is associated with adverse pregnancy outcomes. However, these data are not available for many parts of the world. We assessed the prevalence of gestational diabetes and pregnancy outcomes in Tajikistan. This cohort study included 2438 consecutively recruited representative pregnant women from 8 locations in two cities in Tajikistan, in whom an oral glucose tolerance test (75 g, fasting, 1 h, 2 h) was performed during gestational weeks 24–28. Women with known diabetes and twin pregnancies were excluded. Associations between glucose tolerance test results and pregnancy outcomes were examined. According to the WHO 2013 thresholds, 32.4% of women qualified as having gestational diabetes, the vast majority (29.7%) based on an elevated fasting glucose level (5.1–5.6 mmol/L), while only 2.8% had elevated 1- or 2-hour values or met more than one threshold. Women with only elevated fasting glucose (impaired gestational fasting glycemia) had no evidence of adverse pregnancy outcomes, while those with elevated 1- and/or 2-hour values (impaired gestational glucose tolerance) had more pregnancy complications (infection of urinary tract 1.8 vs. 8.8% p<0.001; preeclampsia 0.7 vs. 10.3% p<0.001) and emergency cesarean sections (4.4 vs. 13.2% p=0.002). Neonates from pregnancies with impaired gestational glucose tolerance had lower APGARs, lower birth weights, lower 30 min glucose levels, and a lower probability of being discharged alive (all p<0.05). In conclusion, the formal prevalence of gestational diabetes is high in Tajikistan; however, this does not translate into adverse pregnancy outcomes for women with impaired gestational fasting glycemia.

Key words

Central Asia - oral glucose tolerance test - maternal outcome - neonatal outcome - neonatal hypoglycemia


Publication History

Received: 26 April 2022
Received: 20 May 2022

Accepted: 31 May 2022

Article published online:
26 July 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Collaboration NCDRF. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016; 387: 1513-1530
    CrossrefPubMedSearch in Google Scholar
  • 2 Cho NH, Shaw JE, Karuranga S. et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271-281
    CrossrefPubMedSearch in Google Scholar
  • 3 Sacks DA, Hadden DR, Maresh M. et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012; 35: 526-528
    CrossrefPubMedSearch in Google Scholar
  • 4 Group HSCR. Metzger BE, Lowe LP, Dyer AR. et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002
    Search in Google Scholar
  • 5 Lowe WL, Scholtens DM, Kuang A. et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): Maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care 2019; 42: 372-380
    CrossrefPubMedSearch in Google Scholar
  • 6 Scholtens DM, Kuang A, Lowe LP. et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): Maternal glycemia and childhood glucose metabolism. Diabetes Care 2019; 42: 381-392
    CrossrefPubMedSearch in Google Scholar
  • 7 Hillier TA, Pedula KL, Schmidt MM. et al. Childhood obesity and metabolic imprinting: The ongoing effects of maternal hyperglycemia. Diabetes Care 2007; 30: 2287-2292
    CrossrefPubMedSearch in Google Scholar
  • 8 Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization Guideline. Diabetes Res Clin Pract 2014; 103: 341-363
    CrossrefPubMedSearch in Google Scholar
  • 9 International Association of D, Pregnancy Study Groups Consensus P. Metzger BE, Gabbe SG, Persson B. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676-682
    CrossrefPubMedSearch in Google Scholar
  • 10 Cheung NW, Jiang S, Athayde N. Impact of the IADPSG criteria for gestational diabetes, and of obesity, on pregnancy outcomes. Aust N Z J Obstet Gynaecol 2018; 58: 553-559
    CrossrefPubMedSearch in Google Scholar
  • 11 Cheung NW, Moses RG. Gestational diabetes mellitus: Is it time to reconsider the diagnostic criteria?. Diabetes Care 2018; 41: 1337-1338
    CrossrefPubMedSearch in Google Scholar
  • 12 Feldman RK, Tieu RS, Yasumura L. Gestational diabetes screening: The International Association of the Diabetes and Pregnancy Study Groups compared with Carpenter-Coustan Screening. Obstet Gynecol 2016; 127: 10-17
    CrossrefPubMedSearch in Google Scholar
  • 13 Parhofer KG, Hasbargen U, Ulugberdiyewa A. et al. Gestational diabetes in Turkmenistan: Implementation of a screening program and first results. Arch Gynecol Obstet 2014; 289: 293-298
    CrossrefPubMedSearch in Google Scholar
  • 14 Hillier TA, Pedula KL, Ogasawara KK. et al. A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med 2021; 38: 895-904
    CrossrefPubMedSearch in Google Scholar
  • 15 McIntyre HD, Jensen DM, Jensen RC. et al. Gestational diabetes mellitus: Does one size fit all? A challenge to uniform worldwide diagnostic thresholds. Diabetes Care 2018; 41: 1339-1342
    CrossrefPubMedSearch in Google Scholar
  • 16 Kong JM, Lim K, Thompson DM. Evaluation of the International Association of the Diabetes in pregnancy study group new criteria: Gestational diabetes project. Can J Diabetes 2015; 39: 128-132
    CrossrefPubMedSearch in Google Scholar
  • 17 Meloncelli NJL, Barnett AG, D’Emden M. et al. Effects of changing diagnostic criteria for gestational diabetes mellitus in Queensland, Australia. Obstet Gynecol 2020; 135: 1215-1221
    CrossrefPubMedSearch in Google Scholar
  • 18 Gillman MW, Oakey H, Baghurst PA. et al. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care 2010; 33: 964-968
    CrossrefPubMedSearch in Google Scholar
  • 19 ACOG Practice Bulletin No. 190 Gestational Diabetes Mellitus. Obstet Gynecol 2018; 131: e49-e64
    Search in Google Scholar
  • 20 Tripathi R, Verma D, Gupta VK. et al. Evaluation of 75 g glucose load in non-fasting state [Diabetes in Pregnancy Study group of India (DIPSI) criteria] as a diagnostic test for gestational diabetes mellitus. Indian J Med Res 2017; 145: 209-214
    PubMedSearch in Google Scholar
  • 21 Kapur A, McIntyre HD, Divakar H. et al. Towards a global consensus on GDM diagnosis: Light at the end of the tunnel?. Int J Gynaecol Obstet 2020; 149: 257-261
    CrossrefPubMedSearch in Google Scholar
  • 22 Benhalima K, Van Crombrugge P, Moyson C. et al. The sensitivity and specificity of the glucose challenge test in a universal two-step screening strategy for gestational diabetes mellitus using the 2013 World Health Organization criteria. Diabetes Care 2018; 41: e111-e112
    CrossrefPubMedSearch in Google Scholar
  • 23 McIntyre HD, Oats JJN, Kihara AB. et al. Update on diagnosis of hyperglycemia in pregnancy and gestational diabetes mellitus from FIGO’s Pregnancy & Non-Communicable Diseases Committee. Int J Gynaecol Obstet 2021; 154: 189-194
    CrossrefPubMedSearch in Google Scholar
  • 24 Pillay J, Donovan L, Guitard S. et al. Screening for gestational diabetes: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021; 326: 539-562
    Search in Google Scholar